DK0687295T3 - Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof - Google Patents

Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof

Info

Publication number
DK0687295T3
DK0687295T3 DK94909585T DK94909585T DK0687295T3 DK 0687295 T3 DK0687295 T3 DK 0687295T3 DK 94909585 T DK94909585 T DK 94909585T DK 94909585 T DK94909585 T DK 94909585T DK 0687295 T3 DK0687295 T3 DK 0687295T3
Authority
DK
Denmark
Prior art keywords
cell line
human
lymphoblastoid cell
secreting anti
antibody
Prior art date
Application number
DK94909585T
Other languages
Danish (da)
English (en)
Inventor
Reiko F Irie
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of DK0687295T3 publication Critical patent/DK0687295T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3053—Skin, nerves, brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK94909585T 1993-02-26 1994-02-09 Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof DK0687295T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/026,320 US5419904A (en) 1990-11-05 1993-02-26 Human B-lymphoblastoid cell line secreting anti-ganglioside antibody
PCT/US1994/001469 WO1994019457A1 (fr) 1993-02-26 1994-02-09 Lignee de cellules b-lymphoblastoides humaines secretant un anticorps anti ganglioside

Publications (1)

Publication Number Publication Date
DK0687295T3 true DK0687295T3 (da) 2004-04-05

Family

ID=21831157

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94909585T DK0687295T3 (da) 1993-02-26 1994-02-09 Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof

Country Status (11)

Country Link
US (1) US5419904A (fr)
EP (1) EP0687295B1 (fr)
JP (2) JP4796682B2 (fr)
AT (1) ATE255633T1 (fr)
AU (1) AU687791B2 (fr)
CA (1) CA2156857C (fr)
DE (1) DE69433378T2 (fr)
DK (1) DK0687295T3 (fr)
ES (1) ES2211877T3 (fr)
PT (1) PT687295E (fr)
WO (1) WO1994019457A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072249C (fr) * 1991-06-28 2003-06-17 Saiko Hosokawa Anticorps monoclonal humain liant specifiquement a la surface d'un antigene des membranes des cellules cancereuses
EP0598998B1 (fr) * 1992-09-07 2004-05-19 Kyowa Hakko Kogyo Co., Ltd Anticorps humanisés réagissant avec le ganglioside GM2
US6063379A (en) * 1993-12-09 2000-05-16 Centro De Inmunologia Molecular Anti-idiotypic monoclonal antibodies and compositions including the anti-idiotypic monoclonal antibodies
WO1997040140A1 (fr) * 1996-04-22 1997-10-30 The Wistar Institute Of Anatomy And Biology Anticorps anti-idiotypiques contre gd2 et leurs applications
EP0975673A2 (fr) * 1997-04-21 2000-02-02 Glycozyme, Inc. Recherche des proteines et peptides glycosiles dans des fluides biologiques
WO1999043815A2 (fr) * 1998-02-27 1999-09-02 Novopharm Biotech Inc. Anticorps monoclonaux humains capables de reconnaitre de maniere oligospecifique les principaux gangliosides associes aux tumeurs, et leurs procedes d'utilisation
US6194551B1 (en) * 1998-04-02 2001-02-27 Genentech, Inc. Polypeptide variants
US6528624B1 (en) * 1998-04-02 2003-03-04 Genentech, Inc. Polypeptide variants
KR20060067983A (ko) * 1999-01-15 2006-06-20 제넨테크, 인크. 효과기 기능이 변화된 폴리펩티드 변이체
US7183387B1 (en) 1999-01-15 2007-02-27 Genentech, Inc. Polypeptide variants with altered effector function
US6737056B1 (en) * 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US7824864B2 (en) * 2000-05-18 2010-11-02 The United States Of America As Represented By The Secretary Of The Army Detection of human antibodies to squalene in serum
AU2001274855A1 (en) * 2000-05-18 2001-11-26 U.S. Army Medical Research And Material Command Detection of antibodies to squalene in serum
US20020146753A1 (en) * 2001-04-06 2002-10-10 Henrik Ditzel Autoantibodies to glucose-6-phosphate isomerase and their participation in autoimmune disease
AU2002337935B2 (en) * 2001-10-25 2008-05-01 Genentech, Inc. Glycoprotein compositions
DE602004030451D1 (de) 2003-07-15 2011-01-20 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion
EP1688432B1 (fr) 2003-10-09 2011-08-03 Chugai Seiyaku Kabushiki Kaisha Solution stabilisee a concentration elevee en igm
CA2729499A1 (fr) * 2008-06-30 2010-01-07 Morphotek, Inc. Anticorps anti-gd2 et procedes et utilisations associes a ceux-ci
HUE041335T2 (hu) 2011-03-29 2019-05-28 Roche Glycart Ag Antitest FC-variánsok
PE20150361A1 (es) 2012-07-13 2015-03-14 Roche Glycart Ag Anticuerpos biespecificos anti-vegf/anti-ang-2 y su utilizacion en el tratamiento de enfermedades vasculares oculares
EP2925783B1 (fr) 2012-11-30 2020-07-29 Katinger GmbH Anticorps igm recombinant humain efficace contre des cellules cancéreuses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4699880A (en) * 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
DE4107154A1 (de) * 1990-10-11 1992-04-16 Boehringer Mannheim Gmbh Monoklonale antikoerper gegen melanom
US5208146A (en) * 1990-11-05 1993-05-04 The Regents Of The University Of California Murine monoclonal anti-idiotype antibodies
EP0492409A1 (fr) * 1990-12-18 1992-07-01 Ishihara Sangyo Kaisha, Ltd. Anticorps monoclonal humain
WO1993010221A1 (fr) * 1991-11-13 1993-05-27 The Regents Of The University Of California Anticorps chimeriques murins/anti-idiotypes humains monoclonaux

Also Published As

Publication number Publication date
JP2011209287A (ja) 2011-10-20
AU6238094A (en) 1994-09-14
JP4796682B2 (ja) 2011-10-19
CA2156857C (fr) 2006-05-09
WO1994019457A1 (fr) 1994-09-01
DE69433378D1 (de) 2004-01-15
ATE255633T1 (de) 2003-12-15
EP0687295B1 (fr) 2003-12-03
JPH08507209A (ja) 1996-08-06
PT687295E (pt) 2004-04-30
CA2156857A1 (fr) 1994-09-01
US5419904A (en) 1995-05-30
EP0687295A4 (fr) 1997-01-15
DE69433378T2 (de) 2004-10-14
AU687791B2 (en) 1998-03-05
ES2211877T3 (es) 2004-07-16
EP0687295A1 (fr) 1995-12-20

Similar Documents

Publication Publication Date Title
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
ES8705522A1 (es) Un procedimiento para la preparacion de derivados purificados de una glicoproteina.
GB2236529B (en) Cross-linked antibodies and processes for their preparation
ES8607024A1 (es) Anticuerpos monoclonales
DK314586A (da) Monoklonale antistoffer og antigener for humane lungecarcinomer, der ikke er af typen med smaa celler
GB2237020B (en) Cross-linked antibodies and processes for their preparation
ATE73491T1 (de) Hybridomazellen und deren monoklonale antikoerper gegen den humanen pluropotenten granulozyten- kolonie stimulierenden faktor.
NO174855C (no) Monoklonalt antistoff og cellelinje som produserer dette
DE69030494D1 (de) Karzinomverwandtes haptoglobin (hpr)
DE3585049D1 (de) Monoklonale antikoerper.
EP0190033A3 (en) Monoclonal antibody against a ras oncogene p21 related dodecapeptide
ATE58397T1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
DK182188A (da) Humant tumorassocieret antigen
BG60169B2 (bg) Получаване на плурипотентен гранулоцитен колоний-стимулиращ фактор
PT76274A (en) Antibodies and antigens useful in the diagnosis and treatment of cancer
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same